![Scott Platshon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Platshon
Operationeel Directeur bij
PANACEA ACQUISITION CORP. II
Profiel
Mr. Scott B. Platshon is a Chief Business Officer & Executive Vice President at Zymeworks, Inc., a Chief Operating Officer at Panacea Acquisition Corp.
II and a Partner at Ecor1 Capital LLC /Venture Capital/.
He is on the Board of Directors at Theravance Biopharma, Inc., Ajax Therapeutics, Inc. and Kumquat Biosciences, Inc. Mr. Platshon was previously employed as an Independent Director by Silverback Therapeutics, Inc., a Chief Operating Officer by Panacea Acquisition Corp., and a Partner by EcoR1 Capital, LLC.
He also served on the board at Terremoto Biosciences, Inc. He received his undergraduate degree from Stanford University.
Actieve functies van Scott Platshon
| Bedrijven | Functie | Begin |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Operationeel Directeur | 01-01-2021 |
| ZYMEWORKS INC. | Corporate Officer/Principal | 09-04-2026 |
| THERAVANCE BIOPHARMA | Directeur/Bestuurslid | 23-09-2026 |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Directeur/Bestuurslid | 01-05-2021 |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Directeur/Bestuurslid | 01-02-2021 |
Eerdere bekende functies van Scott Platshon
| Bedrijven | Functie | Einde |
|---|---|---|
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Analyst-Equity | 01-03-2026 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Directeur/Bestuurslid | 01-12-2024 |
| ARS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | - |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Operationeel Directeur | - |
Opleiding van Scott Platshon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
87
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EcoR1 Capital, LLC
EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Finance |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Panacea Acquisition Corp.
Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
